A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc.
Pfizer
Celgene
GlaxoSmithKline
University of Wisconsin, Madison
AbbVie
Amgen
Novartis
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Case Comprehensive Cancer Center